These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 4135113)

  • 1. Influence of the mutation "diabetes" on insulin release and islet morphology in mice of different genetic backgrounds.
    Boquist L; Hellman B; Lernmark A; Täljedal IB
    J Cell Biol; 1974 Jul; 62(1):77-89. PubMed ID: 4135113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Garris DR; Garris BL
    Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of long-term beta-cell glucotoxicity in vitro in pancreatic islets isolated from two mouse strains (C57BL/6J; C57BL/KsJ) with different sensitivities of the beta-cells to hyperglycaemia in vivo.
    Svensson C; Sandler S; Hellerström C
    J Endocrinol; 1993 Feb; 136(2):289-96. PubMed ID: 8459194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the insulin secretory defect in genetically diabetic (db/db) mouse.
    Berglund O; Frankel BJ; Hellman B
    Acta Endocrinol (Copenh); 1978 Mar; 87(3):543-51. PubMed ID: 343471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Ca2+ in impaired insulin release from islets of diabetic (C57BL/KsJ-db/db) mice.
    Siegel EG; Wollheim CB; Sharp GW; Herberg L; Renold AE
    Am J Physiol; 1980 Aug; 239(2):E132-8. PubMed ID: 6996492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.
    Fujiwara T; Wada M; Fukuda K; Fukami M; Yoshioka S; Yoshioka T; Horikoshi H
    Metabolism; 1991 Nov; 40(11):1213-8. PubMed ID: 1943750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dynamic insulin secretory response of isolated pancreatic islets of the diabetic mouse. Evidence for a gene dosage effect on insulin secretion.
    Molina JM; Premdas FH; Klenck RE; Eddlestone G; Oldham SB; Lipson LG
    Diabetes; 1984 Nov; 33(11):1120-3. PubMed ID: 6389229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes.
    Moffett RC; Patterson S; Irwin N; Flatt PR
    Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
    Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
    Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of islet cell populations in spontaneously diabetic mice.
    Baetens D; Stefan Y; Ravazzola M; Malaisse-Lagae F; Coleman DL; Orci L
    Diabetes; 1978 Jan; 27(1):1-7. PubMed ID: 340309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice.
    Kawasaki F; Matsuda M; Kanda Y; Inoue H; Kaku K
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E510-8. PubMed ID: 15522998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectification of diabetic state in C57BL/KsJ-db/db mice by the implantation of pancreatic beta cell line MIN6.
    Inada S; Kaneko S; Suzuki K; Miyazaki J; Asakura H; Fujiwara M
    Diabetes Res Clin Pract; 1996 May; 32(3):125-33. PubMed ID: 8858200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse.
    Zhou YP; Berggren PO; Grill V
    Diabetes; 1996 May; 45(5):580-6. PubMed ID: 8621007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of beta-cell specific function of isolated pancreatic islets from hyperglycemic C57BL/KsJ-db/db mice.
    Wilke B; Besch W
    Acta Biol Med Ger; 1982; 41(12):1157-61. PubMed ID: 6765159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A temporal study of somatostatin secretion and its inhibitory effect in genetically diabetic mice (C57BL/KsJ-db/db).
    Basabe JC; Pivetta OH; de Bruno LF; Cresto JC; Aparicio NJ
    Endocrinology; 1983 Dec; 113(6):1927-34. PubMed ID: 6139272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of the pancreatic B-cell during the development of hyperglycaemia in mice homozygous for the mutations "diabetes" (db) and "misty" (m).
    Gunnarsson R
    Diabetologia; 1975 Oct; 11(5):431-8. PubMed ID: 1103367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.
    Diani AR; Sawada G; Wyse B; Murray FT; Khan M
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E116-22. PubMed ID: 14532171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodoacetamide-induced sensitization of the pancreatic beta-cells to glucose stimulation.
    Hellman B; Idahl LA; Lernmark A; Sehlin J; Täljedal IB
    Biochem J; 1973 Apr; 132(4):775-89. PubMed ID: 4198516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
    Yajima K; Hirose H; Fujita H; Seto Y; Fujita H; Ukeda K; Miyashita K; Kawai T; Yamamoto Y; Ogawa T; Yamada T; Saruta T
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E966-71. PubMed ID: 12676649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.